Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

IntroductionThe duration and timing of immunity conferred by COVID-19 vaccination in sub-Saharan Africa are crucial for guiding pandemic policy interventions, but systematic data for this region is scarce. This study investigated the antibody response after AstraZeneca vaccination in COVID-19 conval...

Full description

Bibliographic Details
Main Authors: Jennifer Serwanga, Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka, Laban Kato, Isaac Kitabye, Jackson Sembera, Geoffrey Odoch, Peter Ejou, Amina Nalumansi, Ben Gombe, Monica Musenero, Pontiano Kaleebu, the COVID-19 Immunoprofiling Team, Christine Hermilia Akoli, Deus Mwesigwa, Ivan Ssali, Hellen Nantambi, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Joseph Ssebwana Katende
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
AstraZeneca vaccine
hybrid immunity
IgG
IgM
and IgA antibody responses
Ugandan population
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1183983/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1183983/full

Similar Items